Abivax (ABVX) Change in Working Capital (2024 - 2026)
Abivax (ABVX) posted quarterly Change in Working Capital of -$5.8 million for Q1 2026, down 161.44% year-over-year from $9.5 million in Q1 2025, and up 70.64% quarter-over-quarter from -$19.8 million in Q4 2025.
Abivax (ABVX) Change in Working Capital (2024 - 2026) Analysis & Trends
Abivax's Change in Working Capital history runs 3 years deep, the most recent figure standing at -$5.8 million for Q1 2026.
- In Q1 2026, Change in Working Capital fell 161.44% year-over-year to -$5.8 million; the TTM figure through Mar 2026 stood at -$20.8 million (down 628.49% YoY), while the FY2025 annual figure was -$4.2 million, down 179.49% from the prior year.
- Change in Working Capital for Q1 2026 stood at -$5.8 million, up from -$19.8 million in the prior quarter.
- The five-year high for Change in Working Capital was $11.3 million in Q3 2024, with the low at -$19.8 million in Q4 2025.
- The 3-year median for Change in Working Capital is $1.4 million (2024), against an average of -$1.4 million.
- Peak annual rise in Change in Working Capital reached 139.96% in 2025, while the deepest fall reached 1487.05% in 2025.
- Abivax's Change in Working Capital stood at $1.4 million in 2024, then slumped by 1487.05% to -$19.8 million in 2025, then soared by 70.64% to -$5.8 million in 2026.
- Business Quant data shows ABVX's Change in Working Capital at -$5.8 million in Q1 2026, -$19.8 million in Q4 2025, and -$2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | -5.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.82 Mn |
| Mar 31, 2026 | -5.82 Mn |
| Dec 31, 2025 | -19.83 Mn |
| Dec 31, 2025 | -19.83 Mn |
| Sep 30, 2025 | -2.43 Mn |
| Sep 30, 2025 | -2.43 Mn |
| Jun 30, 2025 | 7.30 Mn |
| Jun 30, 2025 | 7.30 Mn |
| Mar 31, 2025 | 9.48 Mn |
| Mar 31, 2025 | 9.48 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 11.29 Mn |
| Sep 30, 2024 | 11.29 Mn |
| Jun 30, 2024 | -18.27 Mn |
| Jun 30, 2024 | -18.27 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Mar 31, 2024 | 4.26 Mn |